CN Patent

CN114641297B — 使用高克拉夫特温度阴离子表面活性剂治疗皮肤病症

Assigned to Alcutis Biotherapy Co ltd · Expires 2024-09-13 · 2y expired

What this patent protects

本发明是用于治疗其中表皮屏障功能降低的皮肤病症(如当患者患有湿疹、特别是特应性皮炎时)的方法和组合物。通过使用含有高克拉夫特温度表面活性剂、优选阴离子表面活性剂的制剂，可以显著地改善表皮屏障功能并且可以降低表皮脂质的提取。

USPTO Abstract

本发明是用于治疗其中表皮屏障功能降低的皮肤病症(如当患者患有湿疹、特别是特应性皮炎时)的方法和组合物。通过使用含有高克拉夫特温度表面活性剂、优选阴离子表面活性剂的制剂，可以显著地改善表皮屏障功能并且可以降低表皮脂质的提取。

Drugs covered by this patent

ruxolitinib-phosphate (RUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: CN114641297B
Jurisdiction: CN
Classification: —
Expires: 2024-09-13
Drug substance claim: No
Drug product claim: No
Assignee: Alcutis Biotherapy Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.